Hence, we need to create spaces so T cells can infiltrate.
Scientists have developed two engineered antibodies in newer UCD experiments.
These antibodies were found to be supremely effective at attaching to Fas receptors and causing bystander cells to self-implode.
This is a definitive marker for bystander treatment efficacy of CAR-T therapy.
Hopeful netizens shared their relief upon reading about the discovery
